Incidence and Risk Factors for Developing Herpes Zoster Among a Cohort of Patients Diagnosed with Lymphoma at a Community Cancer Center
CONCLUSIONSReceiving highly immunosuppressive chemotherapy is an independent risk factor for developing HZ. Patients with the risk factors described here might benefit from antiviral prophylaxis against HZ.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Herpes | Laboratory Medicine | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants